UBS Group’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
1,531,636
+1,523,181
| +18,015% | +$2.47M | ﹤0.01% | 3641 |
|
|
2025
Q1 | $6.07K | Buy |
+8,455
| New | +$6.07K | ﹤0.01% | 7617 |
|
|
2024
Q3 | – | Sell |
-11,201
| Closed | -$11.2K | – | 8802 |
|
|
2024
Q2 | $11.2K | Sell |
11,201
-27,182
| -71% | -$27.2K | ﹤0.01% | 6502 |
|
|
2024
Q1 | $91K | Buy |
38,383
+450
| +1% | +$1.07K | ﹤0.01% | 5115 |
|
|
2023
Q4 | $85.3K | Buy |
37,933
+21,573
| +132% | +$48.5K | ﹤0.01% | 5071 |
|
|
2023
Q3 | $34.7K | Buy |
16,360
+6,142
| +60% | +$13K | ﹤0.01% | 5387 |
|
|
2023
Q2 | $31.6K | Buy |
+10,218
| New | +$31.6K | ﹤0.01% | 5623 |
|
|
2023
Q1 | – | Sell |
-4,087
| Closed | -$27.2K | – | 9062 |
|
|
2022
Q4 | $27.2K | Buy |
+4,087
| New | +$27.2K | ﹤0.01% | 6174 |
|
|
2022
Q3 | – | Sell |
-865
| Closed | -$4K | – | 9728 |
|
|
2022
Q2 | $4K | Buy |
+865
| New | +$4K | ﹤0.01% | 8103 |
|
|
2022
Q1 | – | Sell |
-7,167
| Closed | -$83K | – | 9651 |
|
|
2021
Q4 | $83K | Buy |
7,167
+7,130
| +19,270% | +$82.6K | ﹤0.01% | 5396 |
|
|
2021
Q3 | $1K | Sell |
37
-5,081
| -99% | -$137K | ﹤0.01% | 8098 |
|
|
2021
Q2 | $95K | Sell |
5,118
-1,975
| -28% | -$36.7K | ﹤0.01% | 4880 |
|
|
2021
Q1 | $306K | Buy |
+7,093
| New | +$306K | ﹤0.01% | 4235 |
|